$PGNX after hours Pr. $4.92 Progenics Receives
Post# of 63824

Progenics Receives $40 Million Milestone Following FDA Approval
of RELISTOR for OIC Patients With Chronic Non-Cancer Pain

Website
10-Q 8/8/14
Summary

Shares Outstanding: 69.56M
Float: 54.47M

